MTM Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Buy |
24,241
+3
| +0% | +$139 | 0.38% | 67 |
|
|
2025
Q1 | $1.44M | Buy |
24,238
+2
| +0% | +$119 | 0.56% | 46 |
|
|
2024
Q4 | $1.37M | Sell |
24,236
-1,023
| -4% | -$57.9K | 0.53% | 51 |
|
|
2024
Q3 | $1.36M | Sell |
25,259
-46
| -0.2% | -$2.48K | 0.53% | 53 |
|
|
2024
Q2 | $1.05M | Sell |
25,305
-3,105
| -11% | -$129K | 0.43% | 66 |
|
|
2024
Q1 | $1.54M | Sell |
28,410
-149
| -0.5% | -$8.08K | 0.64% | 45 |
|
|
2023
Q4 | $1.47M | Sell |
28,559
-599
| -2% | -$30.7K | 0.67% | 43 |
|
|
2023
Q3 | $1.69M | Buy |
29,158
+1
| +0% | +$58 | 0.85% | 31 |
|
|
2023
Q2 | $1.86M | Buy |
29,157
+1
| +0% | +$64 | 0.91% | 28 |
|
|
2023
Q1 | $2.02M | Hold |
29,156
| – | – | 1.04% | 23 |
|
|
2022
Q4 | $2.1M | Sell |
29,156
-1,306
| -4% | -$94K | 1.09% | 22 |
|
|
2022
Q3 | $2.17M | Buy |
30,462
+1
| +0% | +$71 | 1.23% | 20 |
|
|
2022
Q2 | $2.34M | Hold |
30,461
| – | – | 1.26% | 19 |
|
|
2022
Q1 | $2.23M | Sell |
30,461
-161
| -0.5% | -$11.8K | 1.08% | 24 |
|
|
2021
Q4 | $1.91M | Sell |
30,622
-670
| -2% | -$41.8K | 0.91% | 30 |
|
|
2021
Q3 | $1.85M | Sell |
31,292
-2,440
| -7% | -$144K | 1.01% | 26 |
|
|
2021
Q2 | $2.25M | Buy |
33,732
+3,041
| +10% | +$203K | 1.18% | 21 |
|
|
2021
Q1 | $1.94M | Buy |
30,691
+2,551
| +9% | +$161K | 1.09% | 25 |
|
|
2020
Q4 | $1.75M | Buy |
+28,140
| New | +$1.75M | 1.08% | 24 |
|